Variations in survival and outcomes between Her-2+ve breast cancer subtypes following the introduction of trastuzumab

Emma Holian

Research output: Other contribution (Published) › Other contribution

Original languageEnglish (Ireland)
Media of outputANET COS
Publication statusPublished - 1 Apr 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Cite this